Teijin Past Earnings Performance
Past criteria checks 0/6
Teijin's earnings have been declining at an average annual rate of -51.5%, while the Chemicals industry saw earnings growing at 9.9% annually. Revenues have been growing at an average rate of 5.3% per year.
Key information
-51.5%
Earnings growth rate
-51.5%
EPS growth rate
| Chemicals Industry Growth | 6.6% |
| Revenue growth rate | 5.3% |
| Return on equity | -11.0% |
| Net Margin | -4.3% |
| Last Earnings Update | 30 Sep 2024 |
Recent past performance updates
Recent updates
Some Confidence Is Lacking In Teijin Limited's (TSE:3401) P/S
Nov 07
Be Wary Of Teijin (TSE:3401) And Its Returns On Capital
Oct 17Teijin (TSE:3401) Has A Somewhat Strained Balance Sheet
Sep 18Investor Optimism Abounds Teijin Limited (TSE:3401) But Growth Is Lacking
Aug 04A Look At The Fair Value Of Teijin Limited (TSE:3401)
Jun 10There May Be Underlying Issues With The Quality Of Teijin's (TSE:3401) Earnings
May 21Teijin (TSE:3401) Will Be Looking To Turn Around Its Returns
Apr 09Teijin (TSE:3401) Will Pay A Dividend Of ¥15.00
Mar 21Teijin Limited's (TSE:3401) Share Price Matching Investor Opinion
Mar 16Teijin (TSE:3401) Is Due To Pay A Dividend Of ¥15.00
Feb 28Revenue & Expenses Breakdown
How Teijin makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
| Date | Revenue | Earnings | G+A Expenses | R&D Expenses |
|---|---|---|---|---|
| 30 Sep 24 | 1,033,772 | -44,786 | 195,801 | 42,560 |
| 30 Jun 24 | 1,059,051 | 13,490 | 264,329 | 0 |
| 31 Mar 24 | 1,032,773 | 10,599 | 190,830 | 42,560 |
| 31 Dec 23 | 1,013,251 | -7,190 | 194,341 | 31,935 |
| 30 Sep 23 | 1,014,802 | -25,811 | 178,445 | 31,935 |
| 30 Jun 23 | 1,019,758 | -23,108 | 176,690 | 31,935 |
| 31 Mar 23 | 1,018,751 | -17,695 | 173,966 | 31,935 |
| 31 Dec 22 | 1,004,148 | -9,733 | 173,052 | 33,341 |
| 30 Sep 22 | 983,122 | 9,163 | 172,878 | 33,341 |
| 30 Jun 22 | 943,999 | 20,628 | 168,258 | 33,341 |
| 31 Mar 22 | 926,054 | 23,158 | 163,721 | 33,341 |
| 31 Dec 21 | 913,776 | -7,646 | 174,470 | 32,719 |
| 30 Sep 21 | 895,756 | -1,088 | 166,662 | 32,719 |
| 30 Jun 21 | 883,288 | -2,558 | 160,199 | 32,719 |
| 31 Mar 21 | 836,512 | -6,662 | 153,683 | 32,719 |
| 31 Dec 20 | 816,027 | 21,908 | 150,159 | 34,482 |
| 30 Sep 20 | 811,847 | 20,804 | 151,760 | 34,482 |
| 30 Jun 20 | 818,238 | 20,171 | 154,886 | 34,482 |
| 31 Mar 20 | 853,746 | 25,252 | 158,505 | 34,482 |
| 31 Dec 19 | 876,399 | 34,470 | 159,947 | 36,422 |
| 30 Sep 19 | 885,211 | 31,593 | 161,041 | 36,422 |
| 30 Jun 19 | 886,836 | 36,353 | 159,275 | 36,422 |
| 31 Mar 19 | 888,589 | 45,057 | 159,036 | 36,422 |
| 31 Dec 18 | 879,958 | 46,582 | 159,989 | 35,926 |
| 30 Sep 18 | 869,749 | 50,281 | 156,514 | 35,926 |
| 30 Jun 18 | 853,120 | 51,641 | 155,326 | 35,926 |
| 31 Mar 18 | 834,985 | 45,556 | 152,655 | 35,926 |
| 31 Dec 17 | 820,788 | 55,795 | 152,997 | 35,416 |
| 30 Sep 17 | 792,896 | 57,946 | 150,452 | 35,416 |
| 30 Jun 17 | 765,304 | 52,093 | 151,512 | 35,416 |
| 31 Mar 17 | 741,291 | 50,133 | 149,177 | 35,416 |
| 31 Dec 16 | 734,635 | 30,233 | 158,220 | 33,285 |
| 30 Sep 16 | 751,740 | 27,996 | 157,421 | 33,285 |
| 30 Jun 16 | 772,409 | 31,336 | 187,456 | 0 |
| 31 Mar 16 | 790,748 | 31,090 | 154,024 | 33,285 |
| 31 Dec 15 | 799,014 | 41,260 | 145,437 | 32,366 |
| 30 Sep 15 | 800,829 | 38,724 | 159,272 | 16,950 |
| 30 Jun 15 | 796,878 | 1,456 | 140,811 | 32,366 |
| 31 Mar 15 | 786,171 | -8,086 | 145,220 | 32,366 |
| 31 Dec 14 | 784,658 | -11,091 | 158,504 | 16,292 |
| 30 Sep 14 | 780,016 | -18,564 | 143,310 | 31,708 |
| 30 Jun 14 | 782,762 | 9,771 | 175,610 | 0 |
| 31 Mar 14 | 784,425 | 8,356 | 144,021 | 32,234 |
| 31 Dec 13 | 780,835 | -24,970 | 128,639 | 49,126 |
Quality Earnings: 3401 is currently unprofitable.
Growing Profit Margin: 3401 is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: 3401 is unprofitable, and losses have increased over the past 5 years at a rate of 51.5% per year.
Accelerating Growth: Unable to compare 3401's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: 3401 is unprofitable, making it difficult to compare its past year earnings growth to the Chemicals industry (14%).
Return on Equity
High ROE: 3401 has a negative Return on Equity (-10.99%), as it is currently unprofitable.